University of Utah
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).
University of Utah: 818 sponsored US clinical trials, 138 recruiting.
University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.
Top-decile sponsor footprint
University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
818 total, page 11 of 17
Characterization of Human Autoantibody Titers After Central Nervous System Insult
NCT03089749
Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices
NCT02547766
Preterm Infants and Nephrocalcinosis
NCT02438267
Mind-Body Intervention for Veterans With PTSD
NCT02224989
Enoxaparin Metabolism in Reconstructive Surgery Patients
NCT02411292
Bacterial Contamination of Operative Splash Basins
NCT02434510
Cognitive Training and Practice Effects in Mild Cognitive Impairment
NCT02301546
Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT02278783
Management Strategies for Patients With Low Back Pain and Sciatica
NCT02391350
Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
NCT02268825
Preventing the Loss of Muscle and Function in Hospitalized Older Adults
NCT02566590
Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
NCT02245217
Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users
NCT02311478
Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma
NCT02200562
HER Salt Lake Initiative
NCT02734199
Outcomes Following Total Knee Arthroplasty
NCT02364011
Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)
NCT02272270
70 vs 110 Degree Side-cut Angles in Femtosecond LASIK
NCT03122535
Patient Education for Patients With Back Pain Referred to Physical Therapy
NCT02648373
Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study
NCT02155127
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
NCT02296346
Loteprednol vs. Prednisolone and Fluorometholone
NCT03123614
Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
NCT02286986
Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT02237417
Multimodal Pain Management Following Primary TKA
NCT02369523
Insole Sensor to Determine Optimal Limb Loading in the Rehabilitation of Ankle Fractures
NCT02334618
Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer
NCT02199197
Regorafenib + Panitumumab for Colorectal Cancers
NCT02199223
Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin
NCT02097953
Personalized Prenatal Care for Low-Risk Pregnancies Using Telemedicine
NCT01970436
Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
NCT02241720
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
NCT02151513
Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer
NCT02019303
308nm Excimer Laser for Treatment of Fingernail Psoriasis
NCT02168933
BLIS - Breastfeeding Levonorgestrel IUD Study
NCT01990703
Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine
NCT01942486
Two Anger Management Programs for Teens.
NCT02001246
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
NCT01998126
Mind-Body Rehabilitative Program for Veterans With mTBI (Mild Traumatic Brain Injury)
NCT01975857
Muscle Afferent Feedback Effects in Patients With Heart Failure
NCT01919918
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
NCT02520726
Probiotic (VSL #3) for Gulf War Illness
NCT02011542
A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
NCT01832259
Uridine Adolescent Bipolar Depression Randomized Controlled Trial
NCT01805440
Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
NCT01948505
Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children
NCT02409277
Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies
NCT01818479
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
NCT01963962
Ultrasonographic Assessment of Carpal Tunnel Syndrome
NCT02196220
Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
NCT01957501
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 145 |
| Phase 2 | 123 |
| Phase 3 | 18 |
| Phase 4 | 27 |
Therapeutic Areas
What is open in the University of Utah pipeline
138 recruiting of 818 indexed (17% open); 492 completed (60%).
Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).
Top condition: Low Back Pain (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Utah: open-pipeline peers nationwide
Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 818 trials (± recruiting share)
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- AdventHealth · 17% recruiting · 95 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this University of Utah page
818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.
- 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.